Differential behavior of sPLA2-V and sPLA2-X in human neutrophils

Biochimica et Biophysica Acta - Molecular and Cell Biology of Lipids

Volumn 1771, Issue 2, 2007, Pages 155-163

  Solodkin Szaingurten, I ^a   Levy, R ^a   Hadad, N ^a  

^a BEN GURION UNIVERSITY OF THE NEGEV   (Israel)

Author keywords

Granulocyte like PLB cell; Neutrophils; PLB 985 cells; Secreted PLA2

Indexed keywords

ENZYME; FORMYLMETHIONYLLEUCYLPHENYLALANINE; LIPOPOLYSACCHARIDE; PHOSPHOLIPASE A2; PHOSPHOLIPASE A2 ALPHA; PHOSPHOLIPASE A2 V; PHOSPHOLIPASE A2 X; UNCLASSIFIED DRUG; GROUP V SECRETORY PHOSPHOLIPASE A2; GROUP X SECRETORY PHOSPHOLIPASE A2; PHOSPHOLIPASE A; PHOSPHOLIPASE A2-ALPHA;

ARTICLE; CELL MEMBRANE; CELL STIMULATION; CONTROLLED STUDY; ENZYME ACTIVATION; ENZYME ACTIVITY; ENZYME ANALYSIS; ENZYME REGULATION; ENZYME RELEASE; HUMAN; HUMAN CELL; NEUTROPHIL; PRIORITY JOURNAL; PROTEIN EXPRESSION; CELL CULTURE; CELL LINE; ENZYMOLOGY; LEUKOCYTE ACTIVATION; PHYSIOLOGY; SECRETION;

CELL LINE; CELLS, CULTURED; ENZYME ACTIVATION; HUMANS; NEUTROPHIL ACTIVATION; NEUTROPHILS; PHOSPHOLIPASES A;

EID: 33846833931     PISSN: 13881981     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bbalip.2006.11.013     Document Type: Article

References (50)

1. Murakami M., Nakatani Y., Atsumi G., Inoue K., and Kudo I. Regulatory functions of phospholipase A2. Crit. Rev. Immunol. 17 (1997) 225-283
2. Tischfield J.A. A reassessment of the low molecular weight phospholipase A2 gene family in mammals. J. Biol. Chem. 272 (1997) 17247-17250
3. Diaz B.L., and Arm J.P. Phospholipase A(2). Prostaglandins Leukot. Essent. Fat. Acids 69 (2003) 87-97
4. Nevalainen T.J., Eerola L.I., Rintala E., Laine V.J., Lambeau G., and Gelb M.H. Time-resolved fluoroimmunoassays of the complete set of secreted phospholipases A2 in human serum. Biochim. Biophys. Acta 1733 (2005) 210-223
5. Suzuki N., Ishizaki J., Yokota Y., Higashino K., Ono T., Ikeda M., Fujii N., Kawamoto K., and Hanasaki K. Structures, enzymatic properties, and expression of novel human and mouse secretory phospholipase A(2)s. J. Biol. Chem. 275 (2000) 5785-5793
6. Ishizaki J., Suzuki N., Higashino K., Yokota Y., Ono T., Kawamoto K., Fujii N., Arita H., and Hanasaki K. Cloning and characterization of novel mouse and human secretory phospholipase A(2)s. J. Biol. Chem. 274 (1999) 24973-24979
7. Kudo I., Murakami M., Hara S., and Inoue K. Mammalian non-pancreatic phospholipases A2. Biochim. Biophys. Acta 1170 (1993) 217-231
8. Weinrauch Y., Elsbach P., Madsen L.M., Foreman A., and Weiss J. The potent anti-Staphylococcus aureus activity of a sterile rabbit inflammatory fluid is due to a 14-kD phospholipase A2. J. Clin. Invest. 97 (1996) 250-257
9. Weinrauch Y., Abad C., Liang N.S., Lowry S.F., and Weiss J. Mobilization of potent plasma bactericidal activity during systemic bacterial challenge. Role of group IIA phospholipase A2. J. Clin. Invest. 102 (1998) 633-638
10. Weiss J., Inada M., Elsbach P., and Crowl R.M. Structural determinants of the action against Escherichia coli of a human inflammatory fluid phospholipase A2 in concert with polymorphonuclear leukocytes. J. Biol. Chem. 269 (1994) 26331-26337
11. Gronroos J.O., Laine V.J., and Nevalainen T.J. Bactericidal group IIA phospholipase A2 in serum of patients with bacterial infections. J. Infect. Dis. 185 (2002) 1767-1772
12. Green J.A., Smith G.M., Buchta R., Lee R., Ho K.Y., Rajkovic I.A., and Scott K.F. Circulating phospholipase A2 activity associated with sepsis and septic shock is indistinguishable from that associated with rheumatoid arthritis. Inflammation 15 (1991) 355-367
13. Chen J., Engle S.J., Seilhamer J.J., and Tischfield J.A. Cloning and recombinant expression of a novel human low molecular weight Ca(2+)-dependent phospholipase A2. J. Biol. Chem. 269 (1994) 2365-2368
14. Balboa M.A., Balsinde J., Winstead M.V., Tischfield J.A., and Dennis E.A. Novel group V phospholipase A2 involved in arachidonic acid mobilization in murine P388D1 macrophages. J. Biol. Chem. 271 (1996) 32381-32384
15. Shinohara H., Balboa M.A., Johnson C.A., Balsinde J., and Dennis E.A. Regulation of delayed prostaglandin production in activated P388D1 macrophages by group IV cytosolic and group V secretory phospholipase A2s. J. Biol. Chem. 274 (1999) 12263-12268
16. Kessen U.A., Schaloske R.H., Stephens D.L., Killermann Lucas K., and Dennis E.A. PGE2 release is independent of upregulation of Group V phospholipase A2 during long-term stimulation of P388D1 cells with LPS. J. Lipid Res. 46 (2005) 2488-2496
17. Han S.K., Kim K.P., Koduri R., Bittova L., Munoz N.M., Leff A.R., Wilton D.C., Gelb M.H., and Cho W. Roles of Trp31 in high membrane binding and proinflammatory activity of human group V phospholipase A2. J. Biol. Chem. 274 (1999) 11881-11888
18. Kim K.P., Rafter J.D., Bittova L., Han S.K., Snitko Y., Munoz N.M., Leff A.R., and Cho W. Mechanism of human group V phospholipase A2 (PLA2)-induced leukotriene biosynthesis in human neutrophils. A potential role of heparan sulfate binding in PLA2 internalization and degradation. J. Biol. Chem. 276 (2001) 11126-11134
19. Degousee N., Ghomashchi F., Stefanski E., Singer A., Smart B.P., Borregaard N., Reithmeier R., Lindsay T.F., Lichtenberger C., Reinisch W., Lambeau G., Arm J., Tischfield J., Gelb M.H., and Rubin B.B. Groups IV, V, and X phospholipases A2s in human neutrophils: role in eicosanoid production and gram-negative bacterial phospholipid hydrolysis. J. Biol. Chem. 277 (2002) 5061-5073
20. Cupillard L., Koumanov K., Mattei M.G., Lazdunski M., and Lambeau G. Cloning, chromosomal mapping, and expression of a novel human secretory phospholipase A2. J. Biol. Chem. 272 (1997) 15745-15752
21. Valentin E., Ghomashchi F., Gelb M.H., Lazdunski M., and Lambeau G. On the diversity of secreted phospholipases A(2). Cloning, tissue distribution, and functional expression of two novel mouse group II enzymes. J. Biol. Chem. 274 (1999) 31195-31202
22. Morioka Y., Saiga A., Yokota Y., Suzuki N., Ikeda M., Ono T., Nakano K., Fujii N., Ishizaki J., Arita H., and Hanasaki K. Mouse group X secretory phospholipase A2 induces a potent release of arachidonic acid from spleen cells and acts as a ligand for the phospholipase A2 receptor. Arch. Biochem. Biophys. 381 (2000) 31-42
23. Bauldry S.A., and Wooten R.E. Leukotriene B4 and platelet activating factor production in permeabilized human neutrophils: role of cytosolic PLA2 in LTB4 and PAF generation. Biochim. Biophys. Acta 1303 (1996) 63-73
24. Marshall L.A., Bolognese B., Winkler J.D., and Roshak A. Depletion of human monocyte 85-kDa phospholipase A2 does not alter leukotriene formation. J. Biol. Chem. 272 (1997) 759-765
25. Roshak A., Sathe G., and Marshall L.A. Suppression of monocyte 85-kDa phospholipase A2 by antisense and effects on endotoxin-induced prostaglandin biosynthesis. J. Biol. Chem. 269 (1994) 25999-26005
26. Kudo I., and Murakami M. Phospholipase A2 enzymes. Prostaglandins Other Lipid Mediat. 68-69 (2002) 3-58
27. Balsinde J., Balboa M.A., and Dennis E.A. Functional coupling between secretory phospholipase A2 and cyclooxygenase-2 and its regulation by cytosolic group IV phospholipase A2. Proc. Natl. Acad. Sci. U. S. A. 95 (1998) 7951-7956
28. Murakami M., Shimbara S., Kambe T., Kuwata H., Winstead M.V., Tischfield J.A., and Kudo I. The functions of five distinct mammalian phospholipase A2S in regulating arachidonic acid release. Type IIa and type V secretory phospholipase A2S are functionally redundant and act in concert with cytosolic phospholipase A2. J. Biol. Chem. 273 (1998) 14411-14423
29. Kuwata H., Yamamoto S., Miyazaki Y., Shimbara S., Nakatani Y., Suzuki H., Ueda N., Murakami M., and Kudo I. Studies on a mechanism by which cytosolic phospholipase A2 regulates the expression and function of type IIA secretory phospholipase A2. J. Immunol. 165 (2000) 4024-4031
30. Dana R., Leto T.L., Malech H.L., and Levy R. Essential requirement of cytosolic phospholipase A2 for activation of the phagocyte NADPH oxidase. J. Biol. Chem. 273 (1998) 441-445
31. Liberty I.F., Raichel L., Hazan-Eitan Z., Pessach I., Hadad N., Schlaeffer F., and Levy R. Cytosolic phospholipase A2 is responsible for prostaglandin E2 and leukotriene B4 formation in phagocyte-like PLB-985 cells: studies of differentiated cPLA2-deficient PLB-985 cells. J. Leukoc. Biol. 76 (2004) 176-184
32. Kaufman M., Leto T., and Levy R. Translocation of annexin I to plasma membranes and phagosomes in human neutrophils upon stimulation with opsonized zymosan: possible role in phagosome function. Biochem. J. 316 (1996) 35-42
33. Hazav P., Shany S., Moran A., and Levy R. Involvement of intracellular pH elevation in the effect of 1,25-dihydroxyvitamin D3 on HL-60 cells. Cancer Res. 49 (1989) 72-75
34. Ancian P., Lambeau G., and Lazdunski M. Multifunctional activity of the extracellular domain of the M-type (180 kDa) membrane receptor for secretory phospholipases A2. Biochemistry 34 (1995) 13146-13151
35. Kjeldsen L., Sengelov H., and Borregaard N. Subcellular fractionation of human neutrophils on Percoll density gradients. J. Immunol. Methods 232 (1999) 131-143
36. Levy R., Rotrosen D., Nagauker O., Leto T.L., and Malech H.L. Induction of the respiratory burst in HL-60 cells. Correlation of function and protein expression. J. Immunol. 145 (1990) 2595-2601
37. Hazan I., Dana R., Granot Y., and Levy R. Cytosolic phospholipase A2 and its mode of activation in human neutrophils by opsonized zymosan. Correlation between 42/44 kDa mitogen-activated protein kinase, cytosolic phospholipase A2 and NADPH oxidase. Biochem. J. 326 (1997) 867-876
38. Balestrieri B., Hsu V.W., Gilbert H., Leslie C.C., Han W.K., Bonventre J.V., and Arm J.P. Group V secretory phospholipase A2 translocates to the phagosome after zymosan stimulation of mouse peritoneal macrophages and regulates phagocytosis. J. Biol. Chem. 281 (2006) 6691-6698
39. Rosenthal M.D., Gordon M.N., Buescher E.S., Slusser J.H., Harris L.K., and Franson R.C. Human neutrophils store type II 14-kDa phospholipase A2 in granules and secrete active enzyme in response to soluble stimuli. Biochem. Biophys. Res. Commun. 208 (1995) 650-656
40. Burgoyne R.D., and Morgan A. Ca2+ and secretory-vesicle dynamics. Trends Neurosci. 18 (1995) 191-196
41. Nusse O., Serrander L., Lew D.P., and Krause K.H. Ca2+-induced exocytosis in individual human neutrophils: high- and low-affinity granule populations and submaximal responses. EMBO J. 17 (1998) 1279-1288
42. Calafat J., Janssen H., Knol E.F., Malm J., and Egesten A. The bactericidal/permeability-increasing protein (BPI) is membrane-associated in azurophil granules of human neutrophils, and relocation occurs upon cellular activation. Apmis 108 (2000) 201-208
43. Silliman C.C., Moore E.E., Zallen G., Gonzalez R., Johnson J.L., Elzi D.J., Meng X., Hanasaki K., Ishizaki J., Arita H., Ao L., Engl K.M., and Banerjee A. Presence of the M-type sPLA(2) receptor on neutrophils and its role in elastase release and adhesion. Am. J. Physiol., Cell Physiol. 283 (2002) 1102-1113
44. Hanasaki K. Mammalian phospholipase A2: phospholipase A2 receptor. Biol. Pharm. Bull. 27 (2004) 1165-1167
45. Touqui L., and Arbibe L. A role for phospholipase A2 in ARDS pathogenesis. Mol. Med. Today 5 (1999) 244-249
46. Bylund J., Karlsson A., Boulay F., and Dahlgren C. Lipopolysaccharide-induced granule mobilization and priming of the neutrophil response to Helicobacter pylori peptide Hp(2-20), which activates formyl peptide receptor-like 1. Infect. Immun. 70 (2002) 2908-2914
47. Sengelov H., Boulay F., Kjeldsen L., and Borregaard N. Subcellular localization and translocation of the receptor for N-formylmethionyl-leucyl-phenylalanine in human neutrophils. Biochem. J. 299 (1994) 473-479
48. Bylund J., Pellme S., Fu H., Mellqvist U.H., Hellstrand K., Karlsson A., and Dahlgren C. Cytochalasin B triggers a novel pertussis toxin sensitive pathway in TNF-alpha primed neutrophils. BMC Cell Biol. 5 (2004) 21
49. Sapirstein A., Spech R.A., Witzgall R., and Bonventre J.V. Cytosolic phospholipase A2 (PLA2), but not secretory PLA2, potentiates hydrogen peroxide cytotoxicity in kidney epithelial cells. J. Biol. Chem. 271 (1996) 21505-21513
50. Kuwata H., Nakatani Y., Murakami M., and Kudo I. Cytosolic phospholipase A2 is required for cytokine-induced expression of type IIA secretory phospholipase A2 that mediates optimal cyclooxygenase-2-dependent delayed prostaglandin E2 generation in rat 3Y1 fibroblasts. J. Biol. Chem. 273 (1998) 1733-1740